The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Four Israeli tech companies have been named in this year’s annual list of Time magazine’s Best Inventions for creations “that are changing how we live, work, play and think about what’s possible,” the publication said. The global list of the 300 groundbreaking inventions includes Apple’s iPhone Duo, AI software that lets non-coders build websites, and […]
This op-ed is authored by Jenny Goldstein, chief development officer of the American Technion Society. For anyone who has faced a cancer diagnosis, or watched someone they love go through one, there is a particular anguish that comes with uncertainty. For me, that feeling is deeply personal. My father, an engineer whose love of science […]
As universities across Israel prepare to begin the new academic year, there is an ever-present sense of resilience among staff, faculty and students. However, Israeli universities are not immune to the same global trends and challenges affecting their counterparts in the United States, particularly the rapid development and adoption of AI. The academic year is […]
Bringing these diverse fields together under one roof is intended to shorten the journey from discovery to application, creating an environment where medical needs can spark new research and promising innovations can move more quickly toward the patients who need them. “The combination of a research hospital and a technological university provides the entire value […]
Prof. Hossam Haick of the Technion – Israel Institute of Technology, one of Israel’s most successful scientists, is really a frustrated karate fighter. As a boy in Nazareth, he joined a karate class and seemed to have found his calling. “I was incredibly competitive,” he says. “I went from one achievement to the next.” But […]
A breast cancer diagnosis can bring a terrifying question: Will chemotherapy save my life, or will I endure its painful side effects without any benefit? In this video, influencer Aija Mayrock goes inside the Technion – Israel Institute of Technology with Dr. Gil Shamai to explore an AI breakthrough that could help doctors answer that […]
A Breakthrough From the Technion Together with collaborators from leading medical centers in Israel, the United States, Europe, and Australia, Shamai and his team at the Technion have developed an AI model that predicts both the risk that breast cancer will return and whether a patient is likely to benefit from chemotherapy — offering a […]
At the Technion, Israel Institute of Technology, the future often begins with a deceptively simple question: What can we do today that we could not do before? “Science and engineering have never been about yesterday’s tasks. They’ve always been about the future,” said Prof. Lihi Zelnik-Manor, vice president of External Relations and Resource Development at […]
An expert in the field of healthcare innovation and entrepreneurship, Yonat Granot has been managing, consulting and mentoring companies and entrepreneurs, for over 20 years. She is currently Tel Aviv senior life-science innovation officer for the Royal Innovation Center Denmark (under foreign office and higher education), and of course – she’s a proud Technion Alum! […]
Cornell Tech is welcoming 13 startups to its Roosevelt Island campus this fall through three Runway Startup Program at the Jacobs Technion-Cornell Institute at Cornell Tech: the Runway Startup Postdoc Program, the Spinouts Program, and the new Runway Pilot Program for Technology Founders. The cohort includes five ventures led by Ph.D. founders, two companies participating […]
Artificial intelligence is rapidly becoming an integral part of our lives, and a working tool for professionals in a variety of fields, including medicine, which integrates AI in order to reach faster, more accurate, and more efficient diagnoses. But to what extent can AI truly be relied upon when it comes to complex medical decisions? […]
Two patients receive the same immunotherapy for the same cancer. In one, the tumor retreats and stays gone for years. In the other, the treatment does nothing. Oncologists still have no reliable way to tell these patients apart before therapy begins. Why does immunotherapy succeed for some and fail for others? A new study led […]